SCI时时刷

search
Fedratinib for the treatment of myelofibrosis: a critical appraisal of clinical trial and “real-world” data
Fedratinib is a predominantly JAK2 inhibitor that has shown efficacy in untreated and ruxolitinib-exposed patients with my...
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance
Post-transplant tyrosine kinase inhibitors (TKIs) show promise in preventing relapse after allogeneic hematopoietic cell t...
Role of Population Based Studies in Advancing our Knowledge of Myelodysplastic Syndromes
Role of Population Based Studies in Advancing our Knowledge of Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are myeloid neoplasms characterized by high molecular and genomic heterogeneity. According...
Construction and characterization of chimeric FcγR T cells for universal T cell therapy
Construction and characterization of chimeric FcγR T cells for universal T cell therapy
Several approaches are being explored for engineering off-the-shelf chimeric antigen receptor (CAR) T cells. In this study...
Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications
Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications
Immune checkpoint therapies have spearheaded drug innovation over the last decade, propelling cancer treatments toward a n...
Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer
Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer
Radiotherapy is the primary treatment modality for most head and neck cancers (HNCs). Despite the addition of chemotherapy...
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group
Given the heterogeneity of acute myeloid leukemia patients, it is necessary to identify patients considered fit for intens...
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
Treatment with obinutuzumab plus venetoclax reshapes the TRB repertoire of CLL patients
The TRB repertoire was characterized in 137 samples, representing 59 patients from the HOVON-139/GIVE trial at trial entry...
Liquid biopsy entering clinical practice: Past discoveries, current insights, and future innovations
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fff2...
131I-mIBG therapy in relapsed/refractory neuroblastoma: A weapon from the future past
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8fff2...
Circular RNAs as key regulators in cancer hallmarks: New progress and therapeutic opportunities
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 8ff1e...
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications
More than a decade following the discovery of Calreticulin (CALR) mutations as drivers of myeloproliferative neoplasms (MP...
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria
Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease (VOD), is a life-threatening complicat...